SEC Form 4 · accession 0001638599-16-001674
Lipocine Inc. · LPCN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Morgan R Brown
Officer — EVP and CFO
Period of report
Dec 7, 2016
Accepted (ET)
Dec 8, 2016 · 10:48 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001535955
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.61 | Dec 7, 2016 | A | 50,000 | A | Dec 7, 2017 | Dec 7, 2016 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 7, 2017, while the remaining 2/3 of the shares subject to the award vesting monthly on a prorata basis over the following two years.